SCHEMBL19981641

SCHEMBL19981641

CCN(CC)C(=O)CNC(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
TSHR P16473 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
GAA P10253 1/20 0.41
CA12 O43570 3/20 0.40
CA14 Q9ULX7 2/20 0.40
CA1 P00915 2/20 0.40
CA7 P43166 1/20 0.40
HSD17B10 Q99714 1/20 0.39
CTSK P43235 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LMNA P02545 1/20 0.38
CA2 P00918 2/20 0.37
CA9 Q16790 1/20 0.36
EPHX1 P07099 1/20 0.36
CTSS P25774 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21716653 0.89 ALDH1A1 (0.42) ALDH1A1MEN1KMT2ATSHRTDP1
SCHEMBL19176849 0.87 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ATSHRTDP1
SCHEMBL21887790 0.84 MEN1 (0.43) ALDH1A1MEN1KMT2ATSHRTDP1
SCHEMBL19212990 0.83 ALDH1A1 (0.39) ALDH1A1MEN1KMT2ATSHRTDP1
SCHEMBL14586333 0.82 MAOA (0.43) ALDH1A1MEN1KMT2ATSHRTDP1
SCHEMBL19824265 0.82 TDP1 (0.49) ALDH1A1MEN1KMT2ATSHRTDP1
SCHEMBL5768805 0.82 ALDH1A1 (0.50) ALDH1A1MEN1KMT2ATDP1MAOA
SCHEMBL14586334 0.82 ALDH1A1 (0.45) ALDH1A1MEN1KMT2ATSHRTDP1
SCHEMBL1328516 0.81 TDP1 (0.46) ALDH1A1MEN1KMT2ATSHRTDP1
SCHEMBL1116455 0.81 MEN1 (0.41) ALDH1A1MEN1KMT2ATSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210355104-A1 ADENOSINE RECEPTOR BINDING COMPOUNDS NIKANG THERAPEUTICS, INC. (US) 2021-11-18 US disclosed
EP-3820474-A1 ADENOSINE RECEPTOR BINDING COMPOUNDS Nikang Therapeutics, Inc. (US) 2021-05-19 EP disclosed
CN-112423758-A Adenosine receptor binding compounds 尼康治疗公司 2021-02-26 CN disclosed
WO-2018053222-A1 TETRAHYDROISOQUINOLINE KAPPA OPIOID ANTAGONISTS RESEARCH TRAINGLE INSTITUTE (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210355104-A1 ADENOSINE RECEPTOR BINDING COMPOUNDS ADORA2A, ADORA1, ADORA3 ALDH1A1 944/4885MEN1 2816/4885KMT2A 3927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.